Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 2Urogenital Neoplasms 1Solid Neoplasm 1Sarcoma 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Hematologic Neoplasms 1Hematologic Diseases 1Health Education 1Communication 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1Adenocarcinoma of Lung 1

Interventions

Carboplatin 3Taxes 2Radiotherapy 2Radiosurgery 2Radiation 2Paclitaxel 2Nivolumab 2veliparib 1tislelizumab 1spartalizumab 1sotorasib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1enzalutamide 1apatinib 1Radiotherapy, Image-Guided 1Radiotherapy, Conformal 1Platinum 1Pemetrexed 1Morphine 1Midazolam 1Letrozole 1Ipilimumab 1Immunoglobulin G 1Granulocyte Colony-Stimulating Factor 1Geriatric Assessment 1Fulvestrant 1Filgrastim 1Etoposide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Adenocarcinoma of Lung × Geriatric Assessment × Clear all
NCT04533451 2025-06-13

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
101 enrolled 21 charts
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡